Provided by Tiger Fintech (Singapore) Pte. Ltd.

Global Partners LP

53.95
-0.7600-1.39%
Post-market: 53.950.00000.00%16:05 EDT
Volume:60.80K
Turnover:3.30M
Market Cap:1.82B
PE:22.39
High:54.92
Open:54.35
Low:53.84
Close:54.71
Loading ...

GLP J-REIT Achieves Top Environmental Certifications

TIPRANKS
·
25 Dec 2024

Jim Cramer on Conagra Brands, Inc. (CAG): ‘I Think Conagra Actually Has A Line Of GLP-1 Foods’

Insider Monkey
·
24 Dec 2024

Vivani Medical: Strategic Innovation in GLP-1 Obesity Treatment Justifies Buy Rating

TIPRANKS
·
22 Dec 2024

Vivani reports start of first human trial of GLP-1 implant, says H.C. Wainwright

TIPRANKS
·
21 Dec 2024

Novo Is Ready to Ramp Up GLP-1 Manufacturing Following $11B Factory Deal -- Barrons.com

Dow Jones
·
20 Dec 2024

End to tirzepatide shortage has read on Hims GLP-1 trajectory, says Leerink

TIPRANKS
·
19 Dec 2024

Darden Watching GLP-1 Drugs -- Market Talk

Dow Jones
·
19 Dec 2024

Lexaria Bioscience begins dosing for GLP-1 study #4

TIPRANKS
·
19 Dec 2024

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

Business Wire
·
19 Dec 2024

Lexaria's Registered GLP-1 Study #4 Begins Dosing

ACCESSWIRE
·
19 Dec 2024

Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Business Wire
·
19 Dec 2024

Merck Enters Obesity Space, Buys Rights to Hansoh's Oral GLP-1 Drug

Zacks
·
19 Dec 2024

EXCLUSIVE: Vivani Medical Initiates First Human Clinical Trial With GLP-1 Implant For Weight Loss In Australia

Benzinga
·
19 Dec 2024

2 stocks to buy & 3 shorts as GLP-1s approach a new frontier

LiveWire
·
19 Dec 2024

Merck, Hansoh Pharma Sign Global License Deal for Investigational Oral GLP-1 Receptor Agonist

MT Newswires Live
·
18 Dec 2024

enVVeno Medical completes final wave of implants in pre-clinical GLP study

TIPRANKS
·
16 Dec 2024